Family-based analysis of candidate genes for polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2306-2315

  Ewens, Kathryn G ^a   Stewart, Douglas R ^b   Ankener, Wendy ^a   Urbanek, Margrit ^c   McAllister, Jan M ^d   Baig, K Maravet ^e   Parker, Stephen C J ^b   Margulies, Elliot H ^b   Legro, Richard S ^f   Dunaif, Andrea ^c   Strauss III, Jerome F ^e   Spielman, Richard S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYTOCHROME P450 17; SMAD4 PROTEIN; SOMATOMEDIN C RECEPTOR; ACTIN BINDING PROTEIN; FBN3 PROTEIN, HUMAN; PROOPIOMELANOCORTIN;

ACVR2A GENE; ADIPOQ GENE; ALLELE; ARTICLE; CAPN5 GENE; CHROMOSOME 19P; CONTROLLED STUDY; CYP11A GENE; ENPP1 GENE; EPHX1 GENE; FAMILY; FEM1A GENE; FEM1B GENE; FEMALE; FOLLOW UP; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC SCREENING; GENOTYPE; H6PD GENE; HAPLOTYPE; HSD17B2 GENE; HSD17B6 GENE; HUMAN; IL1A GENE; INHBA GENE; INHBB GENE; INSL3 GENE; INSR GENE; LEP GENE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; POMC GENE; PRIORITY JOURNAL; SGTA GENE; SHBG GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SRD5A1 GENE; SRD5A2 GENE; TRANSMISSION DISEQUILIBRIUM TEST; GENE FREQUENCY; GENETICS; METHODOLOGY; NUCLEAR FAMILY; RISK FACTOR;

FAMILY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; MICROFILAMENT PROTEINS; NUCLEAR FAMILY; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PRO-OPIOMELANOCORTIN; RISK FACTORS;

EID: 77952781592     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2703     Document Type: Article

References (41)

1. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352: 1223-1236
2. Sam S, Dunaif A 2003 Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14:365-370
3. Legro RS, Driscoll D, Strauss 3rd JF, Fox J, Dunaif A 1998 Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95:14956-14960 (Pubitemid 29003738)
4. Menke MN, Strauss 3rd JF 2007 Genetic approaches to polycystic ovarian syndrome. Curr Opin Obstet Gynecol 19:355-359
5. Urbanek M 2007 The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 3:103-111
6. Simoni M, Tempfer CB, Destenaves B, Fauser BC 2008 Functional genetic polymorphisms and female reproductive disorders. Part I: polycystic ovary syndrome and ovarian response. Hum Reprod Update 14:459-484
7. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss 3rd JF, Spielman RS, Dunaif A 1999 Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 96:8573-8578
8. Stewart DR, Dombroski BA, Urbanek M, Ankener W, Ewens KG, Wood JR, Legro RS, Strauss 3rd JF, Dunaif A, Spielman RS 2006 Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J Clin Endocrinol Metab 91:4112-4117
9. Urbanek M, Woodroffe A, Ewens KG, Diamanti-Kandarakis E, Legro RS, Strauss 3rd JF, Dunaif A, Spielman RS 2005 Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab 90:6623-6629
10. Urbanek M, Sam S, Legro RS, Dunaif A 2007 Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab 92:4191-4198
11. Grigorescu F, New genetic strategies in understanding insulin resistance of polycystic ovary syndrome in human populations. Proc 11th World Congress of Gynecological Endocrinology, Florence, Italy, 2004 (Abstract SS30)
12. Tucci S, Futterweit W, Concepcion ES, Greenberg DA, Villanueva R, Davies TF, Tomer Y 2001 Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab 86:446-449
13. Villuendas G, Escobar-Morreale HF, Tosi F, Sancho J, Moghetti P, San Millán JL2003 Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome. Fertil Steril 79:219-220
14. Prodoehl MJ, Hatzirodos N, Irving-Rodgers HF, Zhao ZZ, Painter JN, Hickey TE, Gibson MA, Rainey WE, Carr BR, Mason HD, Norman RJ, Montgomery GW, Rodgers RJ 2009 Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol Hum Reprod 15:829-841
15. Corson GM, Charbonneau NL, Keene DR, Sakai LY 2004 Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues. Genomics 83:461-472
16. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, Sakai LY 2003 Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril- associated protein. J Biol Chem 278:2750-2757
17. Rosairo D, Kuyznierewicz I, Findlay J, Drummond A 2008 Transforming growth factor-β: its role in ovarian follicle development. Reproduction 136:799-809
18. Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, Reed JM, Madden MC, Mehan RS 2008 Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 294: E918-E927
19. Amthor H, Christ B, Rashid-Doubell F, Kemp CF, Lang E, Patel K 2002 Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth. Dev Biol 243:115-127
20. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K 2004 Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol 270:19-30
21. Gonzá lez A, Sáez ME, Aragón MJ, Galán JJ, Vettori P, Molina L, Rubio C, Real LM, Ruiz A, Ramírez-Lorca R 2006 Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome. Hum Reprod 21:943-951
22. Goodarzi MO, Maher JF, Cui J, Guo X, Taylor KD, Azziz R 2008 FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome. Hum Reprod 23:2842-2849
23. Goodarzi MO, Shah NA, Antoine HJ, Pall M, Guo X, Azziz R 2006 Variants in the 5-α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J Clin Endocrinol Metab 91:4085-4091
24. Goodarzi MO, Xu N, Cui J, Guo X, Chen YI, Azziz R 2008 Small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA), a candidate gene for polycystic ovary syndrome. Hum Reprod 23:1214-1219
25. Heinonen S, Korhonen S, Helisalmi S, Koivunen R, Tapanainen J, Hippeläinen M, Laakso M 2005 Associations between two single nucleotide polymorphisms in the adiponectin gene and polycystic ovary syndrome. Gynecol Endocrinol 21:165-169 (Pubitemid 41597558)
26. Heinonen S, Korhonen S, Helisalmi S, Koivunen R, Tapanainen JS, Laakso M 2004 The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome. Fertil Steril 82:743-745
27. Jones MR, Italiano L, Wilson SG, Mullin BH, Mead R, Dudbridge F, Watts GF, Stuckey BG 2006 Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome. Fertil Steril 86:1438-1446
28. Kolbus A, Walch K, Nagele F, Wenzl R, Unfried G, Huber JC 2007 Interleukin-1 α but not interleukin-1 β gene polymorphism is associated with polycystic ovary syndrome. J Reprod Immunol 73:188-193
29. Korhonen S, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Hippeläinen M, Heinonen S 2003 Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome. Fertil Steril 79:1353-1357
30. San Millán JL, Botella-Carretero JI, Alvarez-Blasco F, Luque-Ramírez M, Sancho J, Moghetti P, Escobar-Morreale HF 2005 A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11β-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome. J Clin Endocrinol Metab 90:4157-4162
31. Abecasis GR, Cherny SS, Cookson WO, Cardon LR 2002 Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30:97-101
32. Spielman RS, McGinnis RE, Ewens WJ 1993 Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516
33. Zhang K, Sun F, Zhao H 2005 HAPLORE: a program for haplotype reconstruction in general pedigrees without recombination. Bioinformatics 21:90-103
34. Barrett JC, Fry B, Maller J, Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265 (Pubitemid 40202029)
35. Parker SC, Hansen L, Abaan HO, Tullius TD, Margulies EH 2009 Local DNA topography correlates with functional noncoding regions of the human genome. Science 324:389-392
36. Greenbaum JA, Pang B, Tullius TD 2007 Construction of a genome-scale structural map at single-nucleotide resolution. Genome Res 17:947-953
37. Eyvazzadeh AD, Pennington KP, Pop-Busui R, Sowers M, Zubieta JK, Smith YR 2009 The role of the endogenous opioid system in polycystic ovary syndrome. Fertil Steril 92:1-12
38. Xia Y, Schneyer AL 2009 The biology of activin: recent advances in structure, regulation and function. J Endocrinol 202:1-12
39. Nelson VL, Legro RS, Strauss 3rd JF, McAllister JM 1999 Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13: 946-957
40. Wickenheisser JK, Quinn PG, Nelson VL, Legro RS, Strauss 3rd JF, McAllister JM 2000 Differential activity of the cytochrome P450 17 α-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 85:2304-2311
41. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM, Mosselman S, Strauss 3rd JF 2003 The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 278:26380-26390